Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1995-8-2
|
pubmed:abstractText |
The survival of host cells following high-dose cytotoxic therapy and allogeneic marrow transplantation has been established previously, but the identity of these cells has not been elucidated in detail. Four patients who received sex-mismatched marrow have been studied for up to 12 months post-transplant using a simultaneous immunophenotyping/fluorescence in situ hybridization technique. The results demonstrate residual host T cells (CD3+), B cells (CD22+) and myeloid cells (CD11c+ and CD13+), and additionally cells of progenitor cell phenotype (CD34+). The long-term persistence of host haemopoiesis may have major relevance to the post-transplant complications of marrow rejection, graft-versus-host disease, and malignant relapse.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1048
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
465-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7794774-B-Lymphocytes,
pubmed-meshheading:7794774-Bone Marrow Transplantation,
pubmed-meshheading:7794774-Cell Survival,
pubmed-meshheading:7794774-Female,
pubmed-meshheading:7794774-Graft vs Host Disease,
pubmed-meshheading:7794774-Hematopoiesis,
pubmed-meshheading:7794774-Humans,
pubmed-meshheading:7794774-T-Lymphocytes,
pubmed-meshheading:7794774-Transplantation, Homologous,
pubmed-meshheading:7794774-Transplantation Chimera
|
pubmed:year |
1995
|
pubmed:articleTitle |
Persistence of multilineage host haemopoiesis following allogeneic bone marrow transplantation.
|
pubmed:affiliation |
Leukaemia Research Fund Centre, Institute of Cancer Research, London.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|